Why Partner in 2025?

As one of our selected event partners, you will be in front of the perfect audience to commercialize the explosion of groundbreaking developments, investments, and promising clinical results that continue to rip through the GLP-1 field. 2025 is the perfect time to build meaningful relationships with key thought leaders and understand how to aid them in developing their pipelines toward commercialization.

The 2nd GLP-1-Based Therapeutics is an exclusive gathering of key pharmaceutical players who are working towards one common goal: to advance specialized, durable, and efficacious GLP-1 agonists and explore the commercial opportunity in indication expansion.

2025’s meeting will offer a unique opportunity to elevate your company’s influence with our bespoke partnership opportunities to ensure you get a piece of the pie and capitalize on this rapidly growing market while supporting the development of GLP-1-based therapeutics.

2025 Partners:

Untitled design (46)
Untitled design (45)
Untitled design (47)

What are the GLP-1-Based Therapeutics Community Searching For?

From our extensive market research with the GLP-1 community, this expanding community of drug developers is constantly looking out for new partners to help them overcome their drug development bottlenecks such as:

  • Preclinical Models: Models of obesity for preclinical research and muscle models to assess side effects of GLP-1s - Diagnostic Imaging: Imaging for obesity and CVRM indications for biomarker and endpoint determination, particularly in indications such as MASH with limited endpoints approved
  • Clinical CROs: GLP-1 developers need specialist CROs to help conduct preclinical studies, design clinical trials, provide regulatory guidance, and develop innovative methodologies
  • CDMOs and Scaling Peptide Providers: With the increasing demand for GLP-1s, drug developers are looking to partner with reliable manufacturers that can adapt to the increase in drug quantity required
  • RWE and HEOR Providers: Drug developers are looking for large data sets on compliance and adherence in the first two years of GLP-1 use

Why Partner?

Showcase your brand to boost awareness in the obesity space and increase your market share through onsite and preconference marketing strategies

Connect with the key decision-makers to gain their trust in your services by presenting your innovative technologies in the main agenda to help them achieve drug development success

Generate new business leads with the competitive intelligence available at this niche and focussed meeting to help you reach your 2025 commercial goals

Understand current toxicology, durability, efficacy manufacturing and formulation challenges, shortfalls, and opportunities for improvement in the GLP-1 field

Contribute to the rapidly evolving field to bring more tolerable, potent and durable GLP-1-based therapies to patients faster

GET IN TOUCH

Who Will You Meet?

Companies Graph
Seniority Graph